PlainRecalls
FDA Drug Low Class III Completed

Votrient (pazopanib) 200 mg tablets, 120-count bottle, Rx Only, Manufactured by: Siegried Barbera, S.L., Barbera del Valles, Spain, Distributed by: Novartis Pharmaceuticals Corp., East Hanover, N.J. 07936, NDC 0078-1077-66

Reported: December 20, 2023 Initiated: November 20, 2023 #D-0149-2024

Product Description

Votrient (pazopanib) 200 mg tablets, 120-count bottle, Rx Only, Manufactured by: Siegried Barbera, S.L., Barbera del Valles, Spain, Distributed by: Novartis Pharmaceuticals Corp., East Hanover, N.J. 07936, NDC 0078-1077-66

Reason for Recall

Failed Dissolution Specifications

Details

Recalling Firm
Siegfried Barbera, SL
Units Affected
2016
Distribution
Nationwide
Location
Barbera Del Valles, N/A

Frequently Asked Questions

What product was recalled?
Votrient (pazopanib) 200 mg tablets, 120-count bottle, Rx Only, Manufactured by: Siegried Barbera, S.L., Barbera del Valles, Spain, Distributed by: Novartis Pharmaceuticals Corp., East Hanover, N.J. 07936, NDC 0078-1077-66. Recalled by Siegfried Barbera, SL. Units affected: 2016.
Why was this product recalled?
Failed Dissolution Specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on December 20, 2023. Severity: Low. Recall number: D-0149-2024.